AbbVie will pay Genmab $750 million upfront, and potentially up to $3.15 billion in additional development, regulatory and […]
Evox’ technology modifies exosomes to deliver drugs to areas currently inaccessible
The drug did not significantly improve overall survival or progression free survival in the first-line setting
Updated Date: Thu, 04 Jun 2020 00:00:00 EDT
Updated Date: Thu, 04 Jun 2020 00:00:00 EDT
Updated Date: Thu, 04 Jun 2020 00:00:00 EDT
Updated Date: Thu, 04 Jun 2020 00:00:00 EDT
Updated Date: Thu, 04 Jun 2020 00:00:00 EDT
AstraZeneca, Emergent BioSolutions sign $87M deal to produce U.S. supply of COVID-19 vaccine kblankenship Thu, 06/11/2020 – 14:49